BerandaATYR • NASDAQ
add
aTyr Pharma Inc
Tutup sebelumnya
$0,71
Rentang hari
$0,69 - $0,70
Rentang tahun
$0,64 - $7,29
Kapitalisasi pasar
67,49 jt USD
Volume Rata-Rata
1,87 jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 190,00 rb | — |
Biaya operasional | 4,80 jt | 44,03% |
Penghasilan bersih | -25,74 jt | -49,16% |
Margin laba bersih | -13,55 rb | — |
Penghasilan per saham | -0,26 | -13,04% |
EBITDA | -26,58 jt | -47,95% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 90,20 jt | 36,70% |
Total aset | 106,65 jt | 16,41% |
Total liabilitas | 26,61 jt | 0,49% |
Total ekuitas | 80,04 jt | — |
Saham yang beredar | 97,99 jt | — |
Harga terhadap nilai buku | 0,86 | — |
Tingkat pengembalian aset | -64,23% | — |
Tingkat pengembalian modal | -74,40% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -25,74 jt | -49,16% |
Kas dari operasi | -20,48 jt | -55,62% |
Kas dari investasi | -20,38 jt | -213,55% |
Kas dari pembiayaan | 29,62 jt | 28.306,67% |
Perubahan kas bersih | -11,24 jt | -339,93% |
Arus kas bebas | -10,67 jt | -64,55% |
Tentang
aTyr Pharma is a public biotherapeutics company that is focused on researching the extracellular functionality and signaling pathways of tRNA synthetases.
The company's lead product candidate, ATYR1923, is a selective modulator of Neuropilin-2 that downregulates both the innate and adaptive immune responses in inflammatory disease states. aTyr is developing ATYR1923 as a potential disease-modifying therapy for patients with interstitial lung disease, a group of rare immune-mediated disorders that cause progressive fibrosis of the lung interstitium and remain a high unmet medical need. ATYR1923 is currently being investigated in a clinical trial in pulmonary sarcoidosis patients.
The company was founded in 2005 and is headquartered in San Diego, California, and led by CEO Sanjay S. Shukla. Wikipedia
Didirikan
1 Jan 2005
Situs
Karyawan
61
